Loading...
Case Summary
A 67-year-old female with squamous cell carcinoma resistant to chemotherapy, radiation, biologics, patches, and exosomes showed tumor regression, pain relief, and enhanced mobility following targeted regenerative therapy.
Presenting Complaint
Patient was diagnosed with squamous cell carcinoma resistant to all traditional treatments including chemotherapy, radiation therapy, biologics, patches, and exosomes. Lesions were present on both legs.
Clinical Course
The patient received six bi-weekly treatment sessions with complete regenerative cell factors delivered IV and via subcutaneous/intramuscular injections around and under both leg wounds.
Clinical Outcomes
Tumor regression with reduced size and severity
Significant pain relief and reduced discomfort
Enhanced mobility and daily function
Improved wound healing and tissue repair
Continued monitoring shows sustained improvement
Patient Information
Age / Gender
67 years / Female
Ethnicity
White
Treatment Protocol
Sessions
6 treatments
Duration
12 weeks (bi-weekly)
Total Units
36 units (6/session)
Administration Routes
Intravenous (IV)Subcutaneous (SQ)Intramuscular (IM)
Download Full Case Study
Access the complete clinical documentation with detailed findings and supporting data.
Disclaimer: This case study is provided for educational and informational purposes only. Individual results may vary. This material is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before beginning any treatment protocol.